ACS Chem Neurosci. 2018 Sep 19;9(9):2241-2251. doi: 10.1021/acschemneuro.8b00017. Epub 2018 Apr 10.
Psychosis is a mental condition that is characterized by hallucinations, delusions, disordered thought, as well as socio-emotional and cognitive impairments. Once developed, it tends to progress into a chronic psychotic illness. Here, the duration of untreated psychosis plays a crucial role: the earlier the treatment begins, relative to the first episode of the disease, the better the patient's functional prognosis. To what extent the success of early interventions relate to progressive changes at the neurotransmitter receptor level is as yet unclear. In fact, very little is known as to how molecular changes develop, transform, and become established following the first psychotic event. One neurotransmitter receptor for which a specific role in psychosis has been discussed is the N-methyl-d-aspartate receptor (NMDAR). This receptor is especially important for information encoding in the hippocampus. The hippocampus is one of the loci of functional change in psychosis, to which a role in the pathophysiology of psychosis has been ascribed. Here, we examined whether changes in NMDAR subunit expression occur along the dorsoventral axis of the hippocampus 1 week and 3 months after systemic treatment with an NMDAR antagonist (MK801) that initiates a psychosis-like state in adult rats. We found early (1 week) upregulation of the GluN2B levels in the dorso-intermediate hippocampus and late (3 month) downregulation of GluN2A expression across the entire CA1 region. The ventral hippocampus did not exhibit subunit expression changes. These data suggest that a differing vulnerability of the hippocampal longitudinal axis may occur in response to MK801-treatment and provide a time-resolved view of the putative development of pathological changes of NMDAR subunit expression in the hippocampus that initiate with an emulated first episode and progress through to the chronic stabilization of a psychosis-like state in rodents.
精神病是一种以幻觉、妄想、思维紊乱以及社会情感和认知障碍为特征的精神状态。一旦发展,它往往会进展为慢性精神病。在这里,未治疗的精神病持续时间起着至关重要的作用:与疾病的第一次发作相比,治疗开始得越早,患者的功能预后就越好。早期干预的成功在多大程度上与神经递质受体水平的渐进性变化有关尚不清楚。事实上,对于分子变化如何发展、转化和确立,人们知之甚少。一种神经递质受体,即 N-甲基-D-天冬氨酸受体(NMDAR),其在精神病中具有特定作用。该受体对海马体中的信息编码尤为重要。海马体是精神病功能变化的一个部位,它被认为与精神病的病理生理学有关。在这里,我们研究了在成年大鼠系统给予 NMDAR 拮抗剂(MK801)后 1 周和 3 个月,NMDAR 亚基表达是否沿海马体的背腹轴发生变化,MK801 会引发类似精神病的状态。我们发现,在背-中间海马体中,GluN2B 水平早期(1 周)上调,在整个 CA1 区晚期(3 个月)下调 GluN2A 表达。腹侧海马体没有表现出亚基表达的变化。这些数据表明,海马体的纵轴可能会因 MK801 治疗而出现不同的脆弱性,并提供了一个时间分辨的视角,观察到 NMDAR 亚基表达的潜在病理性变化在海马体中的发展,这些变化始于模拟的第一次发作,并通过类似于在啮齿动物中慢性稳定的精神病状态进展。